Table 4.

Number of patients in each group with UP/C <1 and <50% baseline in >50% of clinic visits

GroupPatients with UP/C >1 in >50% of VisitsPatients with UP/C >50% of Baseline in >50% of Visits
Prednisone group4 (15%)3 (12%)
O3FA group14 (50%)8 (29%)
Placebo group8 (29%)6 (21%)
Total26 (32%)17 (21%)